Tributyrin supplement for calcium kidney stones
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a supplement called tributyrin can help people who have had calcium-based kidney stones. The aim is to see if it affects stone-related markers in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have had a kidney stone that was mostly calcium (over 80%) in the last 3 years, either passed naturally or removed surgically.
- You are not pregnant or breastfeeding.
- You have not taken any stone medication (except drinking more water) in the past month.
- You have not taken antibiotics in the last 3 months.
- You do not have other conditions like inflammatory bowel disease, diabetes, or a history of certain bowel surgeries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a specific gut bacteria called Oxalobacter formigenes can help people who form calcium oxalate kidney stones. You will eat a controlled diet and provide samples to see how your body handles oxalate, a substance that can lead to stones.
This pilot study looks at how certain gene changes may contribute to calcium oxalate kidney stones. You may be asked for a blood sample and a questionnaire, whether you have a history of stones or not (as a comparison group).
This trial tests a supplement called Neorenal Forte to help clear tiny leftover kidney stone pieces after laser surgery. If you have small fragments left after your procedure, this study may help you get rid of them.
This study looks for “biomarkers,” which are measurable signs in samples like urine or blood, to help understand and detect recurring urinary stone disease. It may help future patients by improving how doctors predict stone recurrence or identify stone types.
This trial tests if using a special suction tube during surgery to remove kidney stones can lower the risk of infection. It is for people with small to medium-sized stones in the kidney or upper ureter.
This trial tests whether a supplement called tributyrin can help improve blood sugar control, reduce inflammation, and lower heart disease risk in people with type 2 diabetes. It may be an option if you have had diabetes for at least a year and have a higher risk of heart problems.
Hear when a new Urolithiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.